Synagis®
Company
MedImmune, Inc.
Use
For prevention/treatment of respiratory syncytial virus (RSV)
Features
First monoclonal antibody approved by the FDA for an infectious disease.
NIH Contribution
Derivation of monoclonal antibodies directed against RSV
Approval Type
FDA
HHS Institute/Agency
NIAID
Inventor(s)
B. Murphy et al.
Year
1998
Tech Cat
Biologic
Request More Info
